2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Marcus Flather et al.|European Heart Journal|2023Cited by 2.3k
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation CarriersIngrid A.W. van Rijsingen, Yigal M. Pinto, Eloisa Arbustini et al.|Journal of the American College of Cardiology|2012Cited by 519
Outcome in Phospholamban R14del CarriersIngrid A.W. van Rijsingen, Arthur A.M. Wilde, Paul A. van der Zwaag et al.|Circulation Cardiovascular Genetics|2014Cited by 190
Gender-Specific Differences in Major Cardiac Events and Mortality in Lamin A/C Mutation CarriersIngrid A.W. van Rijsingen, Yigal M. Pinto, Eline A. Nannenberg et al.|European Journal of Heart Failure|2012Cited by 148
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk predictionTom E. Verstraelen, Arthur A.M. Wilde, Freyja H.M. van Lint et al.|European Heart Journal|2021Cited by 147